Prevalence of Human Papillomavirus Genotypes and Abnormal Pap Smears Among Women in the Military Health System

被引:11
作者
Daly, Christopher M. [1 ,3 ]
Hansen, Shana L. [1 ]
Kwon, Paul O. [2 ]
Roberts, Timothy A. [1 ]
机构
[1] Joint Base San Antonio Lackland AFB, Adolescent Med, San Antonio, TX USA
[2] Walter Reed Army Inst Res, Silver Spring, MD USA
[3] Tripler Army Med Ctr, Adolescent Med, 1 Jarrett White Rd, Honolulu, HI 96589 USA
关键词
Human papillomavirus; Pap smear; Military; Sexually transmitted infections; UNITED-STATES; NATURAL-HISTORY; HPV VACCINE; NATIONAL-HEALTH; CERVICAL-CANCER; YOUNG-WOMEN; INFECTION; RISK; CLEARANCE; DISEASES;
D O I
10.1007/s10900-017-0447-z
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Human papillomavirus infection (HPV) is the most common sexually transmitted infection among United States Military Servicemembers, and present in the majority of cervical cancers. Many of these infections are preventable, but HPV immunization is not mandatory during military service. The objective of this study was to examine the prevalence of vaccine-preventable cervical disease among women enrolled in the San Antonio Military Health System. This is a retrospective cross-sectional study of Pap smear results and HPV genotyping data among Military Servicewomen and beneficiaries. Simple descriptive statistics and logistic regression were used to assess the association between demographics, cervical pathology and high-risk HPV (hrHPV) infection. Pap smears were obtained by 16.9% of women and cervical pathology was present in 28.8% of samples. Compared to the 25-34 year group, 35-44 year-olds were more likely to have an abnormal Pap smear (OR 1.25, CI 1.05-1.50). Of the samples tested, 10.5% were positive for hrHPV. Adjusted multivariable analysis revealed that hrHPV infection was more likely among the 23-34 year group when compared to 35-44 (OR 0.50, CI 0.38-0.67), 45-54 (0.40. CI 0.28-0.59) and 55-65 year groups (0.46, CI 0.30-0.71). Active Duty Servicewomen were more likely to test positive for hrHPV when compared to Active Duty Family Members (OR 0.59, CI 0.45-0.79) and Retiree Family Members (OR 0.59, CI 0.41-0.83). Younger women and Active Duty Servicewomen are significantly more likely to have cervical infection with hrHPV. Future studies should assess the cost-effectiveness of mandatory HPV immunization for military members.
引用
收藏
页码:441 / 447
页数:7
相关论文
共 30 条
[1]  
Agan Brian K, 2013, MSMR, V20, P21
[2]  
[Anonymous], 2013, Cancer Facts and Figures
[3]   The causal relation between human papillomavirus and cervical cancer [J].
Bosch, FX ;
Lorincz, A ;
Muñoz, N ;
Meijer, CJLM ;
Shah, KV .
JOURNAL OF CLINICAL PATHOLOGY, 2002, 55 (04) :244-265
[4]   Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States [J].
Chesson, Harrell W. ;
Ekwueme, Donatus U. ;
Saraiya, Mona ;
Watson, Meg ;
Lowy, Douglas R. ;
Markowitz, Lauri E. .
VACCINE, 2012, 30 (42) :6016-6019
[5]   Childhood Vaccination Coverage Rates Among Military Dependents in the United States [J].
Dunn, Angela C. ;
Black, Carla L. ;
Arnold, John ;
Brodine, Stephanie ;
Waalen, Jill ;
Binkin, Nancy .
PEDIATRICS, 2015, 135 (05) :E1148-E1156
[6]   Human Papillomavirus (HPV) 6, 11, 16, and 18 Prevalence Among Females in the United States-National Health and Nutrition Examination Survey, 2003-2006: Opportunity to Measure HPV Vaccine Impact? [J].
Dunne, Eileen F. ;
Sternberg, Maya ;
Markowitz, Lauri E. ;
McQuillan, Geraldine ;
Swan, David ;
Patel, Sonya ;
Unger, Elizabeth R. .
JOURNAL OF INFECTIOUS DISEASES, 2011, 204 (04) :562-565
[7]   Global Burden of Human Papillomavirus and Related Diseases [J].
Forman, David ;
de Martel, Catherine ;
Lacey, Charles J. ;
Soerjomataram, Isabelle ;
Lortet-Tieulent, Joannie ;
Bruni, Laia ;
Vignat, Jerome ;
Ferlay, Jacques ;
Bray, Freddie ;
Plummer, Martyn ;
Franceschi, Silvia .
VACCINE, 2012, 30 :F12-F23
[8]   Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer [J].
Franco, EL ;
Villa, LL ;
Sobrinho, JP ;
Prado, JM ;
Rousseau, MC ;
Désy, M ;
Rohan, TE .
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (05) :1415-1423
[9]   Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study [J].
Giuliano, Anna R. ;
Lee, Ji-Hyun ;
Fulp, William ;
Villa, Luisa L. ;
Lazcano, Eduardo ;
Papenfuss, Mary R. ;
Abrahamsen, Martha ;
Salmeron, Jorge ;
Anic, Gabriella M. ;
Rollison, Dana E. ;
Smith, Danelle .
LANCET, 2011, 377 (9769) :932-940
[10]   Clinical Validation of the cobas 4800 HPV Test for Cervical Screening Purposes [J].
Heideman, D. A. M. ;
Hesselink, A. T. ;
Berkhof, J. ;
van Kemenade, F. ;
Melchers, W. J. G. ;
Daalmeijer, N. Fransen ;
Verkuijten, M. ;
Meijer, C. J. L. M. ;
Snijders, P. J. F. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (11) :3983-3985